Combined antiretroviral therapy (cART) is a powerful therapy to suppress HIV-1 viral replication. Although in treatment, viral load in plasma remains below the limit of detection in regular assays,
50copiesmL, intermittent episodes of transient viremia (viral blips) over the limit of detection occur in a significant set of HIV-patients under cART. Here, we develop a model-based study of a possible relation between ongoing replication in lymphoid-tissue-based sanctuary sites and viral blips. Given that follicular hyperplasia occurs during lymphoid inflammation as a normal response to infection, we hypothesize that when the diameter of the lymph node follicle increases and crosses a critical size, a viral blip occurs due to cryptic viremia. To demonstrate this we do a theoretical analysis of the model to find those conditions that guarantee that the virus is suppressed in all compartments, and simulate the model for different scenarios of lymph node follicle diameter changes. Thus, to have realistic viral blips, with duration of less than 30 days and with amplitudes relatively close to the limit of detection, the diameter rise rate should be between 0.02 and 0.03 days−1. Moreover, the final diameter of the site is directly related to the steady states of the virus load after the occurrence of a blip. When the steady state viral load after the blip is below the limit of detection, the median value of R0 is 1.45. However, when the median increases beyond 2.1, the steady state of the viral load after the blip often has a value above the limit of detection if the final maximum diameter is sufficiently small. In these cases, for a realistic blip, the maximum final diameters should be greater than 0.7mm so that there is a relative loss of connection between compartments.